Long-term functional outcomes after treatment for localized prostate cancer. Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF (2013) N Engl J Med 368: 436-45 General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL (2003) J Clin Oncol 21: 1147-54 Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. Johnson TK, Gilliland FD, Hoffman RM, Deapen D, Penson DF, Stanford JL, Albertsen PC, Hamilton AS (2004) J Clin Oncol 22: 4193-201 Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC (2004) J Natl Cancer Inst 96: 1358-67 Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF, Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database (2003) Diabetes Care 26: 1093-9 Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment. Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Koyama T, Penson DF (2014) Cancer 120: 1263-71 Survivorship: sexual dysfunction (male), version 1.2013. Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O'Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D, National comprehensive cancer network (2014) J Natl Compr Canc Netw 12: 356-63 Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF (2003) J Urol 169: 1437-42 Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base. Penson DF, Latini DM, Lubeck DP, Wallace K, Henning JM, Lue T (2003) J Urol 169: 1458-61 Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. Latini DM, Penson DF, Colwell HH, Lubeck DP, Mehta SS, Henning JM, Lue TF (2002) J Urol 168: 2086-91 Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. Wessells H, Penson DF, Cleary P, Rutledge BN, Lachin JM, McVary KT, Schade DS, Sarma AV, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2011) J Urol 185: 1828-34 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL (2005) J Urol 173: 1701-5 Isolated infection of a decommissioned penile prosthesis reservoir with Actinomyces neuii. Hsi RS, Hotaling JM, Spencer ES, Bollyky PL, Walsh TJ (2011) J Sex Med 8: 923-6 Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED. Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF (2006) J Sex Med 3: 1059-1067 Longitudinal differences in psychological outcomes for men with erectile dysfunction: results from ExCEED. Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF (2006) J Sex Med 3: 1068-1076 Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other? Yang CC, Porter MP, Penson DF (2006) BJU Int 98: 105-9; discussion 109 Time to raise the bar in localised prostate cancer. Penson DF (2013) BJU Int 112: 278 Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer. Lloyd A, Penson D, Dewilde S, Kleinman L (2008) Prostate Cancer Prostatic Dis 11: 153-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.